Open Access

[Corrigendum] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway

  • Authors:
    • Haibin Wu
    • Xuetao Li
    • Ming Feng
    • Lin Yao
    • Zhitong Deng
    • Guozheng Zao
    • Youxin Zhou
    • Sansong Chen
    • Ziwei Du
  • View Affiliations

  • Published online on: May 23, 2022     https://doi.org/10.3892/or.2022.8337
  • Article Number: 126
  • Copyright : © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

July-2022
Volume 48 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu H, Li X, Feng M, Yao L, Deng Z, Zao G, Zhou Y, Chen S and Du Z: [Corrigendum] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway. Oncol Rep 48: 126, 2022
APA
Wu, H., Li, X., Feng, M., Yao, L., Deng, Z., Zao, G. ... Du, Z. (2022). [Corrigendum] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway. Oncology Reports, 48, 126. https://doi.org/10.3892/or.2022.8337
MLA
Wu, H., Li, X., Feng, M., Yao, L., Deng, Z., Zao, G., Zhou, Y., Chen, S., Du, Z."[Corrigendum] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway". Oncology Reports 48.1 (2022): 126.
Chicago
Wu, H., Li, X., Feng, M., Yao, L., Deng, Z., Zao, G., Zhou, Y., Chen, S., Du, Z."[Corrigendum] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway". Oncology Reports 48, no. 1 (2022): 126. https://doi.org/10.3892/or.2022.8337